Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice

M. Broggini, T. Colombo, M. D'Incalci, [No Value] et.al.

Research output: Contribution to journalArticle

Abstract

Plasma pharmacokinetics of hexamethylmelamine (HMM) and pentamethylmelamine (PMM) were investigated after ip administration of doses of 50 or 100 mg/kg to M5076/73A ovarian tumor-bearing C75BL/6J female mice. The half-life of HMM was 44.5-49 mins; the half-life of PMM was 7.6-8.7 mins. The area under the concentration-versus-time curve (AUC) was also much higher for HMM than for PMM. The AUC for the metabolite N2, N2,N4,N6-tetramethylmelamine (TMM) was seven to ten times higher than that of the parent compounds. After incubation with mouse liver microsomes and cofactors, the rates of metabolism of HMM and PMM were essentially the same. Plasma protein binding was 94%, 71%and 50% for HMM, PMM, and TMM, respectively.

Original languageEnglish
Pages (from-to)669-672
Number of pages4
JournalCancer Treatment Reports
Volume65
Issue number7-8
Publication statusPublished - 1981

Fingerprint

Altretamine
Pharmacokinetics
Area Under Curve
Half-Life
Liver Microsomes
Protein Binding
Blood Proteins
pentamethylmelamine
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice. / Broggini, M.; Colombo, T.; D'Incalci, M.; et.al., [No Value].

In: Cancer Treatment Reports, Vol. 65, No. 7-8, 1981, p. 669-672.

Research output: Contribution to journalArticle

Broggini, M. ; Colombo, T. ; D'Incalci, M. ; et.al., [No Value]. / Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice. In: Cancer Treatment Reports. 1981 ; Vol. 65, No. 7-8. pp. 669-672.
@article{5fdc74a3bb524e998aca28a5b90ed5ba,
title = "Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice",
abstract = "Plasma pharmacokinetics of hexamethylmelamine (HMM) and pentamethylmelamine (PMM) were investigated after ip administration of doses of 50 or 100 mg/kg to M5076/73A ovarian tumor-bearing C75BL/6J female mice. The half-life of HMM was 44.5-49 mins; the half-life of PMM was 7.6-8.7 mins. The area under the concentration-versus-time curve (AUC) was also much higher for HMM than for PMM. The AUC for the metabolite N2, N2,N4,N6-tetramethylmelamine (TMM) was seven to ten times higher than that of the parent compounds. After incubation with mouse liver microsomes and cofactors, the rates of metabolism of HMM and PMM were essentially the same. Plasma protein binding was 94{\%}, 71{\%}and 50{\%} for HMM, PMM, and TMM, respectively.",
author = "M. Broggini and T. Colombo and M. D'Incalci and et.al., {[No Value]}",
year = "1981",
language = "English",
volume = "65",
pages = "669--672",
journal = "Cancer Treatment Reports",
issn = "0361-5960",
publisher = "U.S. National Cancer Institute",
number = "7-8",

}

TY - JOUR

T1 - Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice

AU - Broggini, M.

AU - Colombo, T.

AU - D'Incalci, M.

AU - et.al., [No Value]

PY - 1981

Y1 - 1981

N2 - Plasma pharmacokinetics of hexamethylmelamine (HMM) and pentamethylmelamine (PMM) were investigated after ip administration of doses of 50 or 100 mg/kg to M5076/73A ovarian tumor-bearing C75BL/6J female mice. The half-life of HMM was 44.5-49 mins; the half-life of PMM was 7.6-8.7 mins. The area under the concentration-versus-time curve (AUC) was also much higher for HMM than for PMM. The AUC for the metabolite N2, N2,N4,N6-tetramethylmelamine (TMM) was seven to ten times higher than that of the parent compounds. After incubation with mouse liver microsomes and cofactors, the rates of metabolism of HMM and PMM were essentially the same. Plasma protein binding was 94%, 71%and 50% for HMM, PMM, and TMM, respectively.

AB - Plasma pharmacokinetics of hexamethylmelamine (HMM) and pentamethylmelamine (PMM) were investigated after ip administration of doses of 50 or 100 mg/kg to M5076/73A ovarian tumor-bearing C75BL/6J female mice. The half-life of HMM was 44.5-49 mins; the half-life of PMM was 7.6-8.7 mins. The area under the concentration-versus-time curve (AUC) was also much higher for HMM than for PMM. The AUC for the metabolite N2, N2,N4,N6-tetramethylmelamine (TMM) was seven to ten times higher than that of the parent compounds. After incubation with mouse liver microsomes and cofactors, the rates of metabolism of HMM and PMM were essentially the same. Plasma protein binding was 94%, 71%and 50% for HMM, PMM, and TMM, respectively.

UR - http://www.scopus.com/inward/record.url?scp=0019521944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019521944&partnerID=8YFLogxK

M3 - Article

C2 - 6788370

AN - SCOPUS:0019521944

VL - 65

SP - 669

EP - 672

JO - Cancer Treatment Reports

JF - Cancer Treatment Reports

SN - 0361-5960

IS - 7-8

ER -